undamentalytics Newsletter
Sign in

Surrozen, Inc. balance sheet

At the end of fiscal 2025, Surrozen, Inc. had total assets of $98.7m, total liabilities of $286m and shareholders' equity of −$188m. It held $89.2m in cash against $0 of debt: net cash of $89.2m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents3325363589102
Receivables022205
Total current assets10581413992109
Total assets13789464899116
Accounts payable311011
Total current liabilities141077109
Total debt000000
Total liabilities2713870286334
Shareholders' equity1107638−21−188−219
Net debt (negative = net cash)−33−25−36−35−89−102
Shares outstanding———3m—12m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: HYFT vs SRZNRLAY vs SRZNLCTX vs SRZN

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Surrozen, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Surrozen, Inc.